The proportion of CXCR3+ eTregs in the blood is lower in patients with severe hepatic fibrosis, and the proportion of CCR5+ eTregs may be higher in patients with splenomegaly (study group 1). This evidence concerns the gene CCR5 and Splenomegaly.